(Q44272852)

1 December 2017

title

Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population (English)

1 reference

1 December 2017

0 references

1

1 reference

1 December 2017

Ali Majidpour

16

0 references

Shahnam Arshi

object named as

Shahnam Arshi

15

0 references

Abbas Yazdanbod

object named as

Abbas Yazdanbod

Siavosh Nasseri-Moghaddam

5

0 references

10

object named as

Siavosh Nasseri-Moghaddam

1 reference

1 December 2017

8

Masoud Sotoudeh

1 reference

1 December 2017

2

Shahin Merat

1 reference

1 December 2017

6

Javad Mikaeli

1 reference

1 December 2017

4

Farideh Siavoshi

1 reference

1 December 2017

13

Behnoosh Abedi

1 reference

1 December 2017

11

Akram Pourshams

1 reference

1 December 2017

author name string

Mohammad-Hassan Derakhshan

3

1 reference

1 December 2017

Rasoul Sotoudemanesh

7

1 reference

1 December 2017

Mohammad-Jafar Farahvash

9

1 reference

1 December 2017

Shahab Dolatshahi

12

1 reference

1 December 2017

Masoud Babaei

14

1 reference

1 December 2017

publication date

1 January 2003

1 reference

Journal of Gastroenterology and Hepatology

1 December 2017

published in

1 reference

1 December 2017

volume

18

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

13-17

1 reference

Helicobacter pylori infection and the development of gastric cancer

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Pantoprazole, azithromycin and tinidazole: short duration triple therapy for eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized contr

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Short duration therapy for Helicobacter pylori in Western Australia: the impact of metronidazole resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

In vitro activity of metronidazole against Helicobacter pylori as determined by agar dilution and agar diffusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Furazolidone combination therapies for Helicobacter pylori infection in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Helicobacter pylori--not a good bug after all

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02897.X

10.1046/J.1440-1746.2003.02897.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference